Carla Marini

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications

Impact of novel anti-seizure medications on status epilepticus in Dravet syndrome: a multicenter real-world cohort study.

Impact of novel anti-seizure medications on status epilepticus in Dravet syndrome: a multicenter real-world cohort study.

Journal: Seizure
Published: June 17, 2026

Genetic Etiologies of Epilepsies With Status Epilepticus: Insights From the Italian Pediatric Status Epilepticus Group Cohort.

Genetic Etiologies of Epilepsies With Status Epilepticus: Insights From the Italian Pediatric Status Epilepticus Group Cohort.

Journal: Neurology
Published: March 31, 2026

Comprehensive classification of HCN1 variants linked to neurodevelopmental disorders with and without epilepsy.

Comprehensive classification of HCN1 variants linked to neurodevelopmental disorders with and without epilepsy.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy.

Journal: Epilepsy & behavior : E&B
Published: February 10, 2026

Seizure worsening and sodium channel blockers in HCN1-related epilepsies: A case series.

Seizure worsening and sodium channel blockers in HCN1-related epilepsies: A case series.

Journal: Developmental medicine and child neurology
Published: February 10, 2026

Transition from adolescence to adulthood: Dedicated health services for young people with epilepsy in Italy.

Transition from adolescence to adulthood: Dedicated health services for young people with epilepsy in Italy.

Journal: Epileptic disorders : international epilepsy journal with videotape
Published: November 28, 2025

Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.(Ala106Thr) gain-of-function variant: Structural and phenotypic insights.

Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.(Ala106Thr) gain-of-function variant: Structural and phenotypic insights.

Journal: Epilepsia
Published: October 11, 2025

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score.

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score.

Journal: Epilepsia
Published: October 05, 2025

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

Journal: American journal of human genetics
Published: August 13, 2025

Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.

Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.

Journal: Neurology
Published: June 26, 2025

Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

Clinical and genetic landscape of epilepsies with absence seizures and single-gene etiology.

Journal: Epilepsia
Published: June 24, 2025

Real-world efficacy and safety of cannabidiol in developmental and epileptic encephalopathies.

Real-world efficacy and safety of cannabidiol in developmental and epileptic encephalopathies.

Journal: Epilepsia open
Published: May 30, 2025
Showing 1-12 of 128

Last Updated: 09/26/2026